We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Potential Drug Target for Diabetic Retinopathy

News   Sep 20, 2019 | Original story from Elsevier

 
A Potential Drug Target for Diabetic Retinopathy

ffect of recombinant lysyl oxidase propeptide (rLOX-PP) on the development of acellular capillaries (ACs) and pericyte loss (PL) in rat retinas. A-D: Representative retinal trypsin digest images showing retinal vascular networks of a control rat (A), diabetic (DM) rat (B), rat intravitreally injected with rLOX-PP (C), and rat intravitreally injected with phosphate-buffered saline (PBS) (D). LOX-PP administration promoted the development of ACs (arrows) and PL (arrowheads) associated with diabetic retinopathy. Enlarged images correspond to boxed areas (Right panels of A, B, C, D). Scale bar = 100 μm. Credit: The American Journal of Pathology

 
 
 

RELATED ARTICLES

Liver Fibrosis “Off Switch” Could Help Fight Alcoholic Liver Disease

News

Understanding the process of liver fibrosis, could help researchers develop new ways to prevent or treat conditions such as alcoholic liver disease. A team has now demonstrated for the first time that liver fibrosis progression could potentially be targeted by manipulating a special population of liver cells.

READ MORE

Taking Aim at Gastric Cancer

News

A team has discovered that a novel drug, called “FerriIridium”, is capable of simultaneously diagnosing and treating gastric cancer.

READ MORE

Curvy Cancer-causing Bacterium "Keeps in Shape”

News

New insights into how the cancer-causing stomach bacterium keeps its shape could pave the way for the creation of more-specialized antibiotics.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE